Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,973 | -31,480 | -20,151 | -9,071 | -24,350 |
| Depreciation Amortization | 3,366 | 2,771 | 2,190 | 1,752 | 1,290 |
| Other Working Capital | 3,278 | -474 | -780 | 578 | -1,250 |
| Other Operating Activity | 4,532 | 2,221 | 1,246 | 455 | 1,490 |
| Operating Cash Flow | $-36,797 | $-26,962 | $-17,495 | $-6,286 | $-22,820 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -71,330 | -75,353 | -82,973 | 1,950 | -1,997 |
| PPE Investments | -664 | -545 | -163 | -123 | -240 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3 |
| Investing Cash Flow | $-71,994 | $-75,898 | $-83,136 | $1,827 | $-2,240 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1,561 |
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Debt Repayment | -2,000 | -2,000 | -2,000 | N/A | N/A |
| Common Stock Issued | 77,506 | 77,779 | 77,779 | 69 | 72 |
| Other Financing Activity | 72,411 | 73,235 | 74,019 | 45,003 | -1,001 |
| Financing Cash Flow | $147,917 | $149,014 | $149,798 | $45,072 | $2,510 |
| Beginning Cash Position | 13,899 | 13,899 | 13,899 | 13,899 | 36,450 |
| End Cash Position | 53,025 | 60,053 | 63,066 | 54,512 | 13,890 |
| Net Cash Flow | $39,126 | $46,154 | $49,167 | $40,613 | $-22,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,797 | -26,962 | -17,495 | -6,286 | -22,820 |
| Capital Expenditure | -664 | -545 | -163 | -123 | -249 |
| Free Cash Flow | -37,461 | -27,507 | -17,658 | -6,409 | -23,069 |